Safety Study of Tivanisiran to Treat Dry Eye
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05310422. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will examine the safety of tivanisiran sodium eye drops versus vehicle when dosed once daily for 1 year in subjects with signs and symptoms of dry eye disease (DED).
Study identification
- NCT ID
- NCT05310422
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 301 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2022 (Actual)
- Primary completion
- Oct 11, 2023 (Actual)
- Completion
- Oct 11, 2023 (Actual)
- Last update posted
- Sep 9, 2026
2022 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sylentis Investigative Site | Chandler | Arizona | 85021 | — |
| Sylentis Investigative Site | Phoenix | Arizona | 85032 | — |
| FYDES Investigative Site | Glendale | California | 91204 | — |
| Sylentis Investigative Site | Hemet | California | 92545 | — |
| Sylentis Investigative Site | Los Angeles | California | 85032 | — |
| Sylentis Investigative Site | Murrieta | California | 92562 | — |
| Sylentis Investigative Site | Newport Beach | California | 92663 | — |
| FYDES Investigative Site | Delray Beach | Florida | 33484 | — |
| FYDES Investigative Site | Jacksonville | Florida | 32256 | — |
| Sylentis Investigative Site | Largo | Florida | 33773 | — |
| Sylentis Investigative Site | Morrow | Georgia | 30260 | — |
| Sylentis Investigative Site | Fraser | Michigan | 48026 | — |
| Sylentis Investigative Site | Kansas City | Missouri | 64111 | — |
| FYDES Investigative Site | St Louis | Missouri | 63131 | — |
| Sylentis Investigative Site | Washington | Missouri | 63090 | — |
| Sylentis Investigative Site | Rochester | New York | 14618 | — |
| Sylentis Investigative Site | Asheville | North Carolina | 28803 | — |
| Sylentis Investigative Site | Garner | North Carolina | 27529 | — |
| Sylentis Investigative Site | Cranberry Township | Pennsylvania | 16066 | — |
| Sylentis Investigative Site | Rapid City | South Dakota | 57701 | — |
| Sylentis Investigative Site | Memphis | Tennessee | 38119 | — |
| Sylentis Investigative Site | Austin | Texas | 78731 | — |
| FYDES Investigative Site | El Paso | Texas | 79902 | — |
| Sylentis Investigative Site | San Antonio | Texas | 78215 | — |
| Sylentis Investigative Site | San Antonio | Texas | 78230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05310422, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2026 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.